Drugs

FDA Drug Safety Podcasts

Drug Safety Podcast Banner Graphic

The FDA Drug Safety Podcasts are produced by FDA's Center for Drug Evaluation and Research (CDER). They provide emerging safety information about drugs in conjunction with the release of Public Health Advisories and other drug safety issues.   

Latest Drug Safety Podcasts

Title Date Link to Podcast Link to Transcript
FDA revises description of mental health side effects of stop-smoking medicines Chantix and Zyban to reflect clinical trial findings December 16, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women December 14, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript 
Updated FDA review concludes that use of pioglitazone may be linked to an increased risk of bladder cancer December 12, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript 
FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C October 4, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning August 31, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects July 26, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA strengthens kidney warnings for diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR) June 14, 2016 Listen to This Podcast
Run Time:
00:3:04
Transcript
Update: FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch June 10, 2016 Listen to This Podcast
Run Time:
00:1:12
Transcript
FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse June 7, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about serious bleeding risk with over-the-counter antacid products containing aspirin June 6, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch June 2, 2016 Listen to This Podcast
Run Time:
00:1:58
Transcript
FDA warns that prescribing of Nizoral (ketoconazole) oral tablets for unapproved uses including skin and nail infections continues; linked to patient death May 19, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
Interim clinical trial results find increased risk of leg and foot amputations, mostly affecting the toes, with the diabetes medicine canagliflozin (Invokana, Invokamet); FDA to investigate May 18, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together May 12, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about rare but serious skin reactions with mental health drug olanzapine (Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, and Symbyax) May 10, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about new impulse-control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada) May 3, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA approves brand name change for antidepressant drug Brintellix (vortioxetine) to avoid confusion with antiplatelet drug Brilinta (ticagrelor) May 2, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA to review study examining use of oral fluconazole (Diflucan) in pregnancy April 26, 2016 Listen to This Podcast
Run Time:
00:2:00
Transcript
FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function April 8, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA announced that a safety review has found type 2 diabetes medicines containing saxagliptin and alogliptin may increase the risk of heart failure April 5, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA warns about several safety issues with opioid pain medicines; requires label changes March 29, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript
FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved January 4, 2016 Listen to This Podcast
Run Time:
00:3:00
Transcript

View All Past Podcasts

Page Last Updated: 12/28/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English